GLOBUS MEDICAL INCORPORATED (GMED)

With operations spanning 64 countries ... (NYSE:GMED) develops and sells implantable devices, surgical instruments, and technology solutions for spine, orthopedic, and neurosurgical procedures. ... Annual revenue growth of 30.3% over the past five years was outstanding, reflecting market share gains…

Diluted EPS rose 13.4 percent to $4.24, with operating margin widening 40 basis points to 10.4 percent Aerospace led all segments, posting 15.1 percent revenue growth as Gulfstream delivered 41 jets Backlog closed at $136.5 billion, up 32 percent year over year General Dynamics has reported ...

Globus Medical (GMED) stock drew renewed attention after its recent trading move, with the price closing at $81.42. Investors are now reassessing how its business profile and valuation stack up. See our latest analysis for Globus Medical. That latest move sits within a mixed picture.

Discover more stocks with the Stock Screener. GMED currently appears in the following ChartMill screener lists. GMED generates strong free cash flow relative to its market price. GMED shows strong recent growth in both earnings and sales.

Despite its impressive outperformance over the past year, Wall Street believes General Motors still has room to run, maintaining a moderately optimistic outlook on the stock.